Peripheral Arterial Occlusive Disease
Anti-C. pneumoniae treatment inhibits PAOD progression
Published in TB and Outbreaks Week, May 10th, 2005
Though roxithromycin therapy has been "found to inhibit progression of PAOD, the nature of this effect (antibiotic or anti-inflammatory) has remained elusive," according to scientists in Switzerland.
In a study conducted by P.A. Krayenbuehl and colleagues at the University of Zurich Hospital, the "course of PAOD was prospectively assessed in elderly men during 4 years, comparing 51 C. pneumoniae seropositive (IgG {{>=}}1:128) with 46 seronegative patients (IgG <1:64 and IgA <1:32)."
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Bacteriology
Yersinia species survive and multiply in macrophage phagosomes - Bioterrorism
Multiplexed PCR assay simultaneously detects four biothreat agents - Diagnostics
PCR detects pathogenic leptospires earlier than in tissue culture - Diagnostics
Toxigenic culture sensitive for diagnosis of C. difficile-assoc. diarrhea - Acute Myeloid Leukemia
Arsenic trioxide represses activation of NF-kappa B/COX-2 in AML cells - Anthrax
Project could lead to anthrax drugs - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
